Skip to main content
. 2018 Mar 15;315(1):L25–L40. doi: 10.1152/ajplung.00405.2017

Table 3.

Blood biomarkers of CS exposure-related lung injury in antibiotic-treated pneumonia

Ligand Air (n = 8) Smoke (n = 9–10) Ratio* (S/A) P
MMP-9 13,008 49,834 3.8 0.0085
MIP-1α 73.2 138.2 1.9 0.03
VEGF 1.6 3.0 1.9 0.007
SP-D 68,692 12,6446 1.8 0.04
GM-CSF 5.5 8.5 1.5 0.12
CXCL9 130.4 200.3 1.5 0.045
Ang-2 22,314 34,147 1.5 0.0003
IL-17 7.8 10.5 1.4 0.02
MMP-8 309,065 445,069 1.4 0.009
FGF-2 124 159.7 1.3 0.006
IL-6 31.2 41.6 1.3 0.20
IFNγ 19.4 23.2 1.2 0.50
IL-1β 94.7 105.3 1.1 0.15
IL-2 6.5 7.1 1.1 0.47
MCP-3 1,209 1,299 1.1 0.76
IL-5 14.9 15.0 1.0 >0.99
ICAM-1 54,245 54,956 1.0 0.68
CXCL12 13,254 12,845 1.0 0.67
IL-12 28.2 24.3 0.9 0.09
MCP-1 72.7 63.7 0.9 0.85
TNFR1 1,394 1,259 0.9 0.46
TNFα 13.1 10.8 0.8 0.85
CXCL10 306.7 238.5 0.8 0.57
KC 1,328 732.2 0.6 0.24
IL-10 Too low to measure
IL-13 Too low to measure
IL-4 Too low to measure

Median serum values at 48 h postinfection are expressed in pg/ml. MMP, matrix metalloproteinase; VEGF, vascular endothelial growth factor; SP-D, surfactant protein D; GM-CSF, granulocyte-macrophage colony-stimulating factor; Ang-2, angiopoietin-2; FGF, fibroblast growth factor; IFN, interferon; ICAM, intercellular adhesion molecule; TNF, tumor necrosis factor; TNFR, TNF receptor.

*

Ratio of CS exposed to air exposed, bolded values significant by P < 0.05;

uncorrected P value.